- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01717144
Education in Therapy of Parkinson's Disease (ETPARK)
EVALUATION OF A THERAPEUTIC EDUCATION PROGRAMME IN PARKINSON'S DISEASE
Parkinson's disease (PD) has considerable impact on motor, psychological and social activities and significantly affects the quality of life of patients and their families. To improve the medical care of PD patients, the investigator have developed an educational program specific to PD.
The principal aim of this study is to evaluate the therapeutic education Program, comparing the quality of life of PD patients with or without the educational program after six month and one year follow-up.
The secondary aims are to evaluate the evolution of motor and psychological states in these 2 groups of patients and to compare the medical costs.
This is a monocentric, comparative, prospective randomised study. The investigators will evaluate 120 PD patients, 60 patients benefiting of the educational program and 60 patients with a traditional medical care. Quality of life of PD patients is evaluated using a specific scale (PDQ39) and a generalist scale (SF36) at 6 and 12 months. Motor and psychological states were assessed with UPDRS and HAD Scales. The educational program consisted of both individual and collective educational consultations.
The investigators supposed that the therapeutic education program will improve the quality of life of PD patients. The supposition that this improvement will correlate with the motor and psychological states.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Toulouse, Frankrig, 31000
- UH Toulouse
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients with clinical diagnosis of Parkinson's disease according to the criteria of the UKPDSBB
- Parkinson's disease patients with a score ≤4 on the Hoehn and Year scale
- Patient without cognitive disorders
- Patients treated with dopaminergic antiparkisonian drugs (L-DOPA, dopamine agonists,ICOMT…) or DBS stimulation (since at least 3 month)
- Patients able to fulfil self-administered questionnaire
- Patients affiliated to a social protection program
Exclusion Criteria:
- - Patients suffering from an other pathology causing chronic pain (rheumatic disease, traumatic or orthopaedic pathologies…)
- Parkinson's disease patients with a score>5 on the Hoehn and Yahr scale
- Patients suffering of parkinsonism induce by drugs
- Patients with important tremors during a OFF conditions
- Patients ever included in another study
- Patients with severe psychiatric disease
- Patients under tutelage, curatelle or law protection
- Patients included in an other clinical study
- Patients unable to fulfil scales of the study
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: traditional medical care
patients benefiting of a traditional medical care
|
|
|
Eksperimentel: therapeutic education program
The educational program consisted of both individual and collective educational consultations with a therapeutic education nurse
|
The educational program consisted of both individual and collective educational consultations with a therapeutic education nurse
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Quality of life with the PDQ39 scale
Tidsramme: 1 year
|
1 year
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Quality of life with the SF36 scale
Tidsramme: 1 year
|
1 year
|
|
the motor state with UPDRS (Unified Pakinson's disease Rating Scale)
Tidsramme: 1 year
|
1 year
|
|
The psychological state with HAD (Hospital Anxiety and Depression) scale
Tidsramme: 1 year
|
1 year
|
|
Evaluation of social adaptation with SAS-SR (Social adjustement Scale Sel-Report) scale
Tidsramme: 1 year
|
1 year
|
|
Evaluation of medical costs
Tidsramme: over the 12 months follow-up
|
over the 12 months follow-up
|
Samarbejdspartnere og efterforskere
Sponsor
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 08 150 07
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Parkinsons sygdom
-
University of LahoreAfsluttet
-
Abbott Medical DevicesBaylor College of Medicine; University of HoustonAfsluttet
-
Bial - Portela C S.A.Afsluttet
-
CND Life SciencesDigestive Disease Associates of CTRekrutteringParkinsons sygdom | Parkinson | PARKINSON SYGGE (lidelse) | Parkinsons sygdomForenede Stater
-
Danish Research Centre for Magnetic ResonanceUniversity Hospital Bispebjerg and FrederiksbergRekrutteringSund og rask | Parkinson | Administration af medicinDanmark
-
Mayo ClinicAfsluttet
-
Bezmialem Vakif UniversityRekrutteringParkinsons sygdom | Parkinson | Parkinsons sygdom (PD) | PARKINSON SYGGE (lidelse) | Parkinsons sygdomTyrkiet (Türkiye)
-
CND Life SciencesOregon Health and Science UniversityRekrutteringParkinsons sygdom | Parkinson | Parkinsons sygdom og Parkinsonisme | PARKINSON SYGGE (lidelse)Forenede Stater
-
iRegene Therapeutics Co., Ltd.RekrutteringEn fase I/III klinisk undersøgelse til evaluering af NouvNeu001-injektion til multippel systematrofiMultipel systematrofi - Parkinson subtype (MSA-P)Kina
-
AstraZenecaParexelRekrutteringAvancerede solide tumorerSpanien, Forenede Stater, Sydkorea, Det Forenede Kongerige
Kliniske forsøg med therapeutic education program
-
Universidade Federal de Sao CarlosAfsluttet
-
Centre Hospitalier Universitaire de Saint EtienneRekrutteringNyrekræft (nyrecelle). | Blærekræft (urothelial, overgangscelle).Frankrig
-
University of Arkansas, FayettevilleNational Cancer Institute (NCI); University of California, Los Angeles; Thomas... og andre samarbejdspartnereAktiv, ikke rekrutterendeSygdomme, der kan forebygges ved vaccination | Human Papilloma VirusForenede Stater
-
Brittany L SmallsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Afsluttet
-
Akdeniz UniversityAfsluttetSygeplejerskers opfattelse af intentionalitet | Intentionalitetens Facilitatorer | hindringerne for intentionalitet | Effektiviteten af Mindful Caring Education ProgramKalkun
-
Port Said UniversityIkke rekrutterer endnuTrivsel | KompetenceEgypten
-
Marie HERRAfsluttetForebyggelse af fedme | KræftforebyggelseFrankrig
-
Brittany L SmallsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)AfsluttetType 2 diabetesForenede Stater
-
London School of Hygiene and Tropical MedicineMedical Research Council Unit, The Gambia; Nova Scotia Gambia Association... og andre samarbejdspartnereAfsluttet
-
University of MalayaAfsluttet